Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Immunologic Research
Published in: Immunologic Research 3/2005

01-04-2005

Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in alzheimer disease

Authors: Pablo Iribarren, Ye Zhou, Jinyue Hu, Yingying Le, Ji Ming Wang

Published in: Immunologic Research | Issue 3/2005

Login to get access
Metadata
Title
Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in alzheimer disease
Authors
Pablo Iribarren
Ye Zhou
Jinyue Hu
Yingying Le
Ji Ming Wang
Publication date
01-04-2005
Publisher
Humana Press
Published in
Immunologic Research / Issue 3/2005
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1385/IR:31:3:165

Other articles of this Issue 3/2005

Immunologic Research 3/2005 Go to the issue

OriginalPaper

STAT4

OriginalPaper

Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes

OriginalPaper

The proteasome

OriginalPaper

Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function

OriginalPaper

Immunologic roles of hyaluronan

OriginalPaper

Interaction between HSP73 and HLA-DRB1*0401